{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:44:42Z","timestamp":1793414682913,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopsych.2026.10.009","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:11:18Z","timestamp":1792595478000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Simultaneous measurement of Midbrain and Striatal Dopamine in Schizophrenia using an agonist radiotracer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2142-6353","authenticated-orcid":false,"given":"Mark","family":"Slifstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-3596","authenticated-orcid":false,"given":"Jodi","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Van Snellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Horga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel B.","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Abi-Dargham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.10.009_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopsych.2016.03.2104","article-title":"Pathway-Specific Dopamine Abnormalities in Schizophrenia","volume":"81","author":"Weinstein","year":"2017","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biopsych.2026.10.009_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.biopsych.2017.11.032","article-title":"Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia","volume":"83","author":"Frankle","year":"2018","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.biopsych.2018.02.015","article-title":"Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia","volume":"83","author":"Slifstein","year":"2018","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib7","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biopsych.2026.10.009_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamapsychiatry.2014.2414","article-title":"Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study","volume":"72","author":"Slifstein","year":"2015","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2010.04.038","article-title":"Imaging Dopamine D-3 Receptors in the Human Brain with Positron Emission Tomography, [C-11]PHNO, and a Selective D-3 Receptor Antagonist","volume":"68","author":"Searle","year":"2010","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/syn.20325","article-title":"The Dopamine (D-2\/3) receptor agonist positron emission tomography radiotracer [C-11)-(+)-PHNO is a D-3 receptor preferring agonist in vivo","volume":"60","author":"Narendran","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2026.10.009_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/syn.20658","article-title":"In vivo quantification of regional dopamine-D3 receptor binding potential of (+)PHNO: studies in non-hman primates and transgenic mice","volume":"63","author":"Rabiner","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2026.10.009_bib12","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1021\/jm050155n","article-title":"Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin -9-ol as a potential radiotracer for in vivo Imaging of the dopamine D2 high-affinity state with positron emission tomography","volume":"48","author":"Wilson","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","article-title":"Within-subject comparison of [C-11]-(+)-PHNO and [C-11]raclopride sensitivity to acute amphetamine challenge in healthy humans","volume":"32","author":"Shotbolt","year":"2012","journal-title":"J Cerebr Blood F Met"},{"key":"10.1016\/j.biopsych.2026.10.009_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/jpet.109.163501","article-title":"A comparative evaluation of the dopamine D(2\/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum","volume":"333","author":"Narendran","year":"2010","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"10.1016\/j.biopsych.2026.10.009_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schiz Bull"},{"key":"10.1016\/j.biopsych.2026.10.009_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2967\/jnumed.113.132928","article-title":"Parametric Imaging and Test-Retest Variability of (1)(1)C-(+)-PHNO Binding to D(2)\/D(3) Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner","volume":"55","author":"Gallezot","year":"2014","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"10.1016\/j.biopsych.2026.10.009_bib17","doi-asserted-by":"crossref","unstructured":"Carson R, Barker W, Liow JS (2003): Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. In: Metzier S, editor. 2003 IEEE nuclear science symposium. Portland, OR, USA, pp 3281-3285.","DOI":"10.1109\/NSSMIC.2003.1352597"},{"key":"10.1016\/j.biopsych.2026.10.009_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/mp.2016.21","article-title":"Deficits in striatal dopamine release in cannabis dependence","volume":"22","author":"van de Giessen","year":"2017","journal-title":"Molecular psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"NeuroImage"},{"key":"10.1016\/j.biopsych.2026.10.009_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","article-title":"Parametric imaging of ligand-receptor binding in PET using a simplified reference region model","volume":"6","author":"Gunn","year":"1997","journal-title":"NeuroImage"},{"key":"10.1016\/j.biopsych.2026.10.009_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2026.10.009_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.biopsych.2026.10.009_bib23","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biopsych.2026.10.009_bib24","article-title":"Schizophrenia is associated with increased synaptic dopamine in associative rather than limbic regions of the striatum: Implications for mechanism of action of antipsychotic drugs","volume":"33","author":"Kegeles","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.biopsych.2026.10.009_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/syn.21535","article-title":"Affinity and selectivity of [(1)(1)C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo","volume":"66","author":"Gallezot","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2026.10.009_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/npp.2010.228","article-title":"In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO","volume":"36","author":"Girgis","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.10.009_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41398-019-0681-5","article-title":"On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D(2\/3) receptor agonist radioligand study","volume":"10","author":"Weidenauer","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/026988119901300405","article-title":"Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies","volume":"13","author":"Laruelle","year":"1999","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2026.10.009_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","article-title":"Increased dopamine transmission in schizophrenia: relationship to illness phases","volume":"46","author":"Laruelle","year":"1999","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib30","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1016\/S0021-9258(20)65148-1","article-title":"Anterior pituitary receptors: Demonstration of interconvertible high and low affinity states of the D2 dopamine receptor","volume":"257","author":"Sibley","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2026.10.009_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ijnp\/pyx063","article-title":"Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia","volume":"20","author":"Kubota","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2026.10.009_bib32","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biopsych.2026.10.009_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1755-5949.2010.00162.x","article-title":"All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors","volume":"17","author":"Seeman","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.biopsych.2026.10.009_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0896-6273(03)00192-2","article-title":"Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice","volume":"38","author":"Gainetdinov","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2026.10.009_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2011.07.009","article-title":"Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder","volume":"44","author":"Bychkov","year":"2011","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.biopsych.2026.10.009_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/hup.2375","article-title":"Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese","volume":"29","author":"Tang","year":"2014","journal-title":"human psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.10.009_bib37","first-page":"1845","article-title":"Genetic association between G protein-coupled receptor kinase 6\/beta-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia","volume":"11","author":"Oda","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.biopsych.2026.10.009_bib38","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1074\/jbc.272.7.3871","article-title":"RGS proteins and signaling by heterotrimeric G proteins","volume":"272","author":"Dohlman","year":"1997","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.biopsych.2026.10.009_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacological reviews"},{"key":"10.1016\/j.biopsych.2026.10.009_bib40","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.1807983116","article-title":"Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain","volume":"116","author":"Cassidy","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biopsych.2026.10.009_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108951","article-title":"Activity-dependent somatodendritic dopamine release in the substantia nigra autoinhibits the releasing neuron","volume":"35","author":"Hikima","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2026.10.009_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","article-title":"Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons","volume":"5","author":"Threlfell","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.biopsych.2026.10.009_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85011","article-title":"Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation","volume":"12","author":"Mohebi","year":"2023","journal-title":"Elife"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326016124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326016124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:22:08Z","timestamp":1792707728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326016124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0006322326016124"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.10.009","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous measurement of Midbrain and Striatal Dopamine in Schizophrenia using an agonist radiotracer","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}